MINI FUTURE SHORT ZERTIFIKAT MIT SL - UCB | Real-time Boerse Frankfurt Warrants 07:55:06 2024-07-17 am EDT | ||
| 3.3 EUR | +2.80% |
|
| Current month | -12.53% | ||
| 1 month | -12.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
UCB
Latest news about UCB
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 3.3 | +2.80% |
| 24-07-16 | 3.21 | +3.22% |
| 24-07-15 | 3.11 | +0.65% |
| 24-07-12 | 3.09 | -0.64% |
| 24-07-11 | 3.11 | +0.97% |
Real-time Boerse Frankfurt Warrants
Last update July 17, 2024 at 07:55 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | UCB |
| Issuer | ING Bank |
| WKN | NG8UKK |
| ISIN | DE000NG8UKK5 |
| Date issued | 2024-05-31 |
| Strike | 174.9 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.82 € |
|---|---|
| Lowest since issue | 2.9 € |
| Spread | 0.02 € |
| Spread % | 0.60% |
Company Profile
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Sector
-
Consensus: UCB
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
142.6
EUR
Average target price
140.5
EUR
Spread / Average Target
-1.47%
- Stock Market
- Certificates
- Certificat
